These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6508262)

  • 21. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of tobramycin and gentamicin.
    Britt MR; Garibaldi RA; Wilfert JN; Smith CB
    Antimicrob Agents Chemother; 1972 Sep; 2(3):236-41. PubMed ID: 4790564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal activity of five combinations of penicillin G with aminoglycosides against Streptococcus faecium.
    Le Bouguenec C; Buu-Hoï A
    Eur Heart J; 1984 Oct; 5 Suppl C():29-32. PubMed ID: 6569841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergic activity of beta-lactamines and aminoglycosides vs. bacterial strains treated with sub-MIC concentrations.
    Gismondo MR; Romeo MA; Pappalardo C; Puglisi G; Leonardi R
    Chemioterapia; 1984 Jun; 3(3):175-7. PubMed ID: 6529773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria.
    Just HM; Beckert A; Bassler M; Daschner FD
    Chemotherapy; 1982; 28(5):397-401. PubMed ID: 6291869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
    Shah PM; Belve V
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME; Knight R; Kaye D
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Streptococcus mutans to antimicrobial agents.
    Ferretti JJ; Ward M
    Antimicrob Agents Chemother; 1976 Aug; 10(2):274-6. PubMed ID: 984768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1978 Aug; 14(2):178-84. PubMed ID: 697346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
    Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
    Higurashi Y; Okuzumi K; Yoneyama A; Nakahara K
    Jpn J Antibiot; 1997 Dec; 50(12):907-16. PubMed ID: 9545668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro synergistic antibacterial action of certain combinations of gentamicin and essential oils.
    Rosato A; Piarulli M; Corbo F; Muraglia M; Carone A; Vitali ME; Vitali C
    Curr Med Chem; 2010; 17(28):3289-95. PubMed ID: 20666717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of glycosides of neamine, kanamycin A and gentamicin C.
    Perlman D; Endō T; Hinz RS; Cowan SK; Endō S
    J Antibiot (Tokyo); 1974 Jul; 27(7):525-8. PubMed ID: 4457532
    [No Abstract]   [Full Text] [Related]  

  • 37. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
    Kobayashi F; Saino Y; Koshi T; Hattori Y
    Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria.
    Meyers BR; Leng B; Hirschman SZ
    Antimicrob Agents Chemother; 1975 Dec; 8(6):757-8. PubMed ID: 1211927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.